In a significant advance for harnessing the immune system to treat leukemias, researchers at Fred Hutchinson Cancer Research Center for the first time have successfully infused large numbers of donor T-cells specific for a key anti-leukemic antigen to prolong survival in high-risk and relapsed leukemia patients after stem cell transplantation.
http://www.medicalnewstoday.com/releases/256984.php
http://www.medicalnewstoday.com/releases/256984.php
No comments:
Post a Comment